A post-cycle-therapy stack built on SERMs to restart natural testosterone after a suppressive cycle.
Post-cycle therapy aims to restart the body's own testosterone production after a suppressive anabolic cycle. The standard tools are selective estrogen-receptor modulators (SERMs): enclomiphene or tamoxifen to stimulate the HPTA, sometimes with an aromatase inhibitor early on.
This stack pairs enclomiphene (a cleaner isomer of clomiphene) as the primary restart agent with tamoxifen as the classic alternative. PCT is harm-reduction context for people who are already cycling — it is not an endorsement of the underlying cycle, and proper PCT is bloodwork-guided.
| Compound | Role | Dose | Frequency |
|---|---|---|---|
| Enclomiphene SERM; stimulates the HPTA to restart natural T. | Primary | 12.5-25mg oral daily | Once daily (morning preferred) |
| Tamoxifen Classic SERM alternative/adjunct. | Support | 20-40mg oral daily | Once daily |